Glenmark Pharmaceuticals Ltd. logo

Glenmark Pharmaceuticals Ltd. share price

NSE: GLENMARK · Healthcare

₹2,632.90 -0.27%

Closing price data, updated 17 Nov 2026. 52-week range: -3.0% from high, +45.7% above low.

Price₹2,632.90
Market cap₹74,307 Cr
P/E51.2
P/B6.63
ROE14.1%
ROCE16.2%
Debt / equity0.06
Dividend yield0.00%
EPS₹51.42
Book value₹397.29
Operating margin24.1%
Dipscan score53 / 100
Open full analysis, charts & financials →

Share: WhatsAppX / TwitterTelegram

Glenmark Pharmaceuticals Ltd. shareholding pattern

As of Sep 2026: Promoters 46.65%, FIIs 21.51%, DIIs 17.64%, Government 0.04%, Public 10.44%, Others 3.73%.

HolderSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Promoters46.65%46.65%46.65%46.65%46.65%46.65%
FIIs21.51%20.89%20.34%19.20%20.73%20.62%
DIIs17.64%18.60%19.29%20.09%18.61%17.64%
Government0.04%0.04%0.04%0.04%0.04%0.04%
Public10.44%10.60%10.32%10.77%10.81%11.69%
Others3.73%3.21%3.36%3.26%3.16%3.37%
No. of Shareholders208,414211,418196,105201,584198,789190,210

As filed by the company with the exchanges.

Returns

1 day1 week1 month3 months6 months1 year
-0.27%+1.66%+17.23%+13.49%+12.49%+44.88%

Growth

Sales growth, 3 years+13.5%
Sales growth, 5 years–
Profit growth, 3 years+66.1%
Profit growth, 5 years–
Latest quarter sales vs last year-30.8%
Latest quarter profit vs last year-56.8%

Strengths and weaknesses

Strengths

Weaknesses

Peers in Healthcare

CompanyPriceMarket capP/EROE1 year
Sun Pharmaceutical Industries ₹1,867.50₹4,48,076 Cr40.914.7%+8.8%
Divi's Laboratories Ltd.₹11,080.00₹2,94,139 Cr87.516.2%+69.4%
Torrent Pharmaceuticals Ltd.₹4,691.20₹1,78,438 Cr84.027.1%+22.6%
Apollo Hospitals Enterprise Lt₹8,771.00₹1,26,114 Cr56.221.9%+16.9%
Laurus Labs Ltd.₹2,220.00₹1,19,949 Cr89.518.2%+125.2%
Zydus Lifesciences Ltd.₹1,192.00₹1,18,902 Cr28.419.7%+27.0%
Dr. Reddy's Laboratories Ltd.₹1,377.90₹1,14,778 Cr41.012.1%+13.7%
Cipla Ltd.₹1,394.50₹1,12,658 Cr38.911.8%-8.0%

Frequently asked questions

What is the share price of Glenmark Pharmaceuticals Ltd.?

Glenmark Pharmaceuticals Ltd. (GLENMARK) last closed at ₹2,632.90 (-0.27% on the day).

What is the market cap of Glenmark Pharmaceuticals Ltd.?

About ₹74,307 Cr.

What is the P/E ratio of Glenmark Pharmaceuticals Ltd.?

The price-to-earnings ratio is 51.2, and return on equity is 14.1%.

Figures are calculated from company results and exchange prices and are for information only.